×
<- Back

154121 - A multidisciplinary approach to the changing management of Stage III melanoma patients: New developments in surgical and systemic therapy

  • : Online

Surgical Oncologist, Prof Spillane, discusses the role of SNB and completion lymph node dissection, the current practice undertaken at Melanoma Institute Australia and the implications this has for adjuvant therapy. 
Medical Oncologist, A/Prof Menzies, then outlines recent data from adjuvant systemic therapy clinical trials, discusses how these data translate to the current clinical setting, and offers insights into future developments of adjuvant therapy in melanoma. 

Relevance to General Practice

Management of Stage III melanoma has evolved in recent years and effective systemic therapies are now being used in high risk early stage melanoma patients to reduce the risk of recurrence and improve survival. 
This advancement in treatment has made sentinel node biopsy (SNB) essential for accurate clinical decision-making

Learning outcomes
  • Outline the new developments in surgical and systemic therapy and the GP role in the multidisciplinary management of Stage III melanoma.
  • Discuss the role of SNB and and the implications this has for adjuvant therapy.
  • Develop a systematic and safety approach to allow for the appropriate use of adjuvant therapy in stage III melanoma
  • Delivery
    Title
    154121 - A multidisciplinary approach to the changing management of Stage III melanoma patients: New developments in surgical and systemic therapy
    Location
    Provider Type
    Education Provider
    Duration
    1 hour
    Start Date
    12-Apr-2019
    End Date
    31-Dec-2019
    CPD
    1 hour
    Price
    0.00
    Location
    Online
    Contact Phone
    Log in into view this field.
    4 Views
    Similar Courses and Events
    HealthcareLink